AngioDynamics Inc
NASDAQ:ANGO
AngioDynamics Inc
Tax Provision
AngioDynamics Inc
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
AngioDynamics Inc
NASDAQ:ANGO
|
Tax Provision
$7m
|
CAGR 3-Years
55%
|
CAGR 5-Years
98%
|
CAGR 10-Years
29%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Tax Provision
-$237m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
5%
|
CAGR 10-Years
0%
|
|
Boston Scientific Corp
NYSE:BSX
|
Tax Provision
-$377m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Stryker Corp
NYSE:SYK
|
Tax Provision
-$556m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-12%
|
|
Abbott Laboratories
NYSE:ABT
|
Tax Provision
-$908m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-19%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Tax Provision
-$71.7m
|
CAGR 3-Years
24%
|
CAGR 5-Years
12%
|
CAGR 10-Years
7%
|
See Also
What is AngioDynamics Inc's Tax Provision?
Tax Provision
7m
USD
Based on the financial report for Feb 29, 2024, AngioDynamics Inc's Tax Provision amounts to 7m USD.
What is AngioDynamics Inc's Tax Provision growth rate?
Tax Provision CAGR 10Y
29%
Over the last year, the Tax Provision growth was 240%. The average annual Tax Provision growth rates for AngioDynamics Inc have been 55% over the past three years , 98% over the past five years , and 29% over the past ten years .